Biohit Oyj (HEL:BIOBV)
Finland · Delayed Price · Currency is EUR 2.610
-0.020 (-0.76%)
Aug 28, 2026, 6:20 PM EET
Biohit Oyj Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 16.13 | 15.73 | 14.28 | 13.08 | 10.95 | 9.36 | |
Revenue Growth | 12.95% | 10.14% | 9.23% | 19.41% | 16.98% | 31.42% |
Cost of Revenue | 4.88 | 4.98 | 4.94 | 4.61 | 3.84 | 3.45 |
Gross Profit | 11.25 | 10.75 | 9.34 | 8.46 | 7.11 | 5.92 |
Selling, General & Admin | 4.24 | 4.24 | 4 | 4.09 | 3.63 | 3.45 |
Other Operating Expenses | 3.08 | 2.88 | 2.44 | 2.19 | 1.87 | 1.98 |
Operating Expenses | 7.9 | 7.7 | 6.78 | 6.64 | 5.98 | 7.42 |
Operating Income | 3.35 | 3.05 | 2.56 | 1.83 | 1.13 | -1.5 |
Interest Expense | -0.04 | -0.05 | -0.02 | - | - | - |
Interest & Investment Income | 0.06 | 0.06 | 0.07 | - | - | - |
Currency Exchange Gain (Loss) | -0.07 | -0.07 | - | 0.03 | -0.01 | 0.02 |
Other Non Operating Income (Expenses) | 0.09 | -0.01 | 0.29 | 0.41 | -0.29 | 0.09 |
EBT Excluding Unusual Items | 3.39 | 2.99 | 2.9 | 2.26 | 0.83 | -1.39 |
Gain (Loss) on Sale of Investments | 0.04 | 0.04 | -0.03 | -0.07 | 0.04 | 0.06 |
Gain (Loss) on Sale of Assets | - | - | - | - | - | 0.02 |
Asset Writedown | -0.13 | -0.13 | - | - | - | - |
Pretax Income | 3.3 | 2.9 | 2.87 | 2.2 | 0.87 | -1.31 |
Income Tax Expense | 0.16 | 0.16 | 0.3 | 0.34 | 0.27 | 0.2 |
Net Income | 3.14 | 2.74 | 2.57 | 1.85 | 0.6 | -1.5 |
Net Income to Common | 3.14 | 2.74 | 2.57 | 1.85 | 0.6 | -1.5 |
Net Income Growth | 38.36% | 6.62% | 38.74% | 207.99% | - | - |
Shares Outstanding (Basic) | 15 | 15 | 15 | 15 | 15 | 15 |
Shares Outstanding (Diluted) | 16 | 15 | 15 | 15 | 15 | 15 |
Shares Change | 4.47% | 1.09% | 0.58% | 0.41% | 0.13% | - |
EPS (Basic) | 0.21 | 0.18 | 0.17 | 0.12 | 0.04 | -0.10 |
EPS (Diluted) | 0.20 | 0.18 | 0.17 | 0.12 | 0.04 | -0.10 |
EPS Growth | 33.27% | 6.27% | 41.15% | 200.41% | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -2.06 | -1.36 | 0.18 | 0.65 | 1.79 | -0.48 |
Free Cash Flow Per Share | -0.13 | -0.09 | 0.01 | 0.04 | 0.12 | -0.03 |
Gross Margin | 69.73% | 68.33% | 65.39% | 64.73% | 64.94% | 63.19% |
Operating Margin | 20.78% | 19.40% | 17.90% | 13.96% | 10.30% | -16.02% |
Profit Margin | 19.45% | 17.40% | 17.98% | 14.16% | 5.49% | -16.02% |
Free Cash Flow Margin | -12.79% | -8.66% | 1.29% | 5.00% | 16.34% | -5.10% |
EBITDA | 3.43 | 3.13 | 2.62 | 1.93 | 1.34 | 0.23 |
EBITDA Margin | 21.28% | 19.91% | 18.34% | 14.78% | 12.24% | 2.46% |
D&A For EBITDA | 0.08 | 0.08 | 0.06 | 0.11 | 0.21 | 1.73 |
EBIT | 3.35 | 3.05 | 2.56 | 1.83 | 1.13 | -1.5 |
EBIT Margin | 20.78% | 19.40% | 17.90% | 13.96% | 10.30% | -16.02% |
Effective Tax Rate | 4.94% | 5.62% | 10.43% | 15.67% | 30.76% | - |